Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GSK Gsk Plc

1,599.00
15.50 (0.98%)
19 Apr 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Gsk Plc LSE:GSK London Stock Exchange Ordinary Share GB00BN7SWP63 ORD 31 1/4P
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time   RN  NRN 
   15.50 0.98 1,599.00 1,599.50 1,600.50 1,600.00 1,575.00 1579.5 5,149,016 15:35:14   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.37 65.87B
 Type  Size  Price  Time  Units 
  51,077 1,587.149 17:12:02 GBX
 
Recent News
DateTimeSource
HeadlineMore GSK News
19/04/202415:30LSEG_RNSGSK PLC Director/PDMR Shareholding
17/04/202415:30LSEG_RNSGSK PLC Director/PDMR Shareholding
17/04/202408:46ALNCTOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment
17/04/202408:46ALNCTOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment
17/04/202407:05LSEG_RNSGSK PLC GSK announces additional EAGLE-1 results
17/04/202407:00LSEG_RNSGSK PLC Results from long-term data relating to Shingrix
16/04/202414:11LSEG_RNSGSK PLC Amendment - Director/PDMR Shareholding
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
19/04/202410:37PBBGlaxosmithkline - The recovery32,895
01/02/202410:22PBBGlazoSmithKline - News & Information143
24/09/202321:42PBBGLAXOSMITHKLINE WITH CHARTS & NEWS189
17/04/202319:25PBBGsk zantac2
28/02/202316:35PBBGSK launched Shingrix, which has a far superior shingles prevention effect1
01/09/202215:17PBBGSK - just mucking around4
23/01/202114:27PBBIn Rude Health!2
06/10/202016:28PBBcovid vaccines not needed.. Trump. Calls experimental drugs "miracles from god"3
31/03/202007:46PBBCOVID-19..downgraded no longer high consequence infectious disease1
13/03/202016:09PBBgovt virus chief worked for Glaxo..vested interest with vaccine..ha,ha!2
Newsletter articles for Gsk Plc
DateTimeNewsletterHeadline
28/7/202214:55Tom Winnifrith's N50GSK – half-year update, what now after consumer health business demerger?
28/4/202208:21Tom Winnifrith's N50GlaxoSmithKline – Q1 update, further share price upside as demerger nears
01/3/202210:13Building an income portfolio with Clem ChambersIncome Investors Need To Be More Aggressive Now
24/2/202207:07Tom Winnifrith's N50GlaxoSmithKline – Consumer Healthcare business named and demerger “on track”, still not too late to Buy
11/2/202211:43Tom Winnifrith's N50GlaxoSmithKline – 2021 results, “strong commercial execution”?
29/7/202116:40Tom Winnifrith's N50GlaxoSmithKline – second quarter results, still a recovery buy
02/7/202113:53Tom Winnifrith's N50GlaxoSmithKline – a Recovery Buy
More newsletter articles
Data Downloads for GSK

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)
Technical Analysis for Gsk Plc
Get quick technical analysis for Gsk Plc.
Price Indicators
Evaluate in real-time the trend for this stock with base on twelve different studies.
Candlesticks
Verify the trend for the closing and opening times for this stock or defined reversal patterns.
Support & Resistance
Automatically plot the main lines for support and resistance for this tock highlighting the main levels.

Latest Gsk Plc Articles